CNBC SQUAWK BOX Bank of America CEO: We spend $250 million a year on GLP-1 drugs for our employees

@cnbc

1.3M followers · usually 8.1K views a post

Views

204.2K

Likes

4.2K

Comments

203

Shares

531

Promoted product

Bank of America

Why it worked

The video likely performed well due to the surprising and significant financial figure ($250 million) spent on a trending health topic (GLP-1 drugs), presented by a major CEO, which sparks curiosity and discussion.

Summary

The CEO of Bank of America states that the company spends $250 million annually on GLP-1 drugs for its employees, highlighting this as a significant investment in their workforce. This spending has increased substantially from zero just a few years prior.

Free account

Transcript, structure and on-screen text

4 beats, a 41-word transcript and 6 lines of on-screen text — the parts you need to write your own version.

Create a free account to see the full breakdown

Original caption

Bank of America spends more than $250 million a year covering GLP-1 weight loss drugs for its employees, CEO Brian Moynihan told CNBC's "Squawk Box" on Wednesday, saying the rapidly rising cost is a worthwhile investment in his workforce. Read more at the #linkinbio or the link on screen. #CNBC #bankofamerica #glp1